CHA Biotech

CDMO

South Korea

https://www.chabio.com/

Is this your company? Claim this profile

Advanced Modalities

Analytical & Bioanalytical Services

Regulatory, Tech Transfer & Support Services

Company Overview

About

CHA Biotech is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Quality Control, Stability Testing, Method Development

Therapeutic Areas

Cardiovascular

Endocrinology

Quick Facts

HQ:South Korea

Founded:2007

Employees:1,485

Capabilities & Services

Core Capabilities

Sterile Injectable
Sterile Fill/Finish
Fill/Finish (Vials)

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Cartridge / Pen

Containment Capabilities

OEB 5 (≤1 µg/m³)

Cytotoxic / ADC Handling

Production Scales

Pilot Scale

Phase I Clinical Trials

Clinical

Markets Served

Asia-Pacific

Regulatory Approvals

Drug Approval LWSY7L

PMDA · #APR-ZYOITMJX · 2022-03-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-ZSJBP1M7

Issued: 2020-11-17

Expires: 2025-12-07

Health Canada GMP

Health Canada

Cert #: CERT-QWZIMDRJ

Issued: 2020-02-01

Expires: 2025-04-22

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about CHA Biotech

CHA Biotech is headquartered in South Korea.
CHA Biotech was founded in 2007.
CHA Biotech has 1,485 employees.
CHA Biotech's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).

Find CDMOs like CHA Biotech

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in South Korea CDMOs in Asia Sterile Injectable CDMOs Fill-Finish CDMOs Fill/Finish (Vials) CDMOs Cartridge / Pen CDMOs OEB 5 (≤1 µg/m³) CDMOs Cytotoxic / ADC Handling CDMOs